Skip to main navigation Skip to search Skip to main content

C19: An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients with COVID-19

Project: Research

Project Details

StatusFinished
Effective start/end date03/30/20 → 04/30/22

Funding

  • Department of Health and Human Services: $229,703.09